Thromboprophylaxis clinical trials

Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors

This study aims to see if a blood clot prevention medicine, called thromboprophylaxis, can reduce dangerous blood clots in men with advanced germ cell cancer who are having chemotherapy. We want to find out if it's safe and effective.